Curcumin, the bioactive ingredient in turmeric that lends the spice its iconic golden hue, has long been lauded throughout parts of Asia for its medicinal properties. In past posts, we've shed light on just a few ways that this compound can promote brain health, boost the immune system and even combat the effects of aging. Now, a new study from the Government Medical College in India has indicated that curcumin supplements may also benefit individuals suffering from major depressive disorder.
According to a study abstract available on PubMed, the researchers conducted a randomized controlled trial involving 60 participants who had been diagnosed with the behavioral condition. Citing the fact that curcumin "has shown potential antidepressant-like activity in animal studies," the scientists sought to determine if it could benefit patients when taken in conjunction with the antidepressant fluoxetine.
Over the course of six weeks, the researchers observed that participants who received curcumin and fluoxetine together saw greater benefits as determined by the Hamilton Depression Rating Scale.
"This study provides first clinical evidence that curcumin may be used as an effective and safe modality for treatment in patients with MDD," the researchers concluded.
While further research is necessary before this compound may be introduced in conventional medical treatments, the results of this study are promising for anyone experiencing symptoms of depression.
In addition to this potential benefit, curcumin has also been shown to possibly restrict the spread of cancer, ease rheumatoid arthritis pain and enhance the overall health of middle-aged individuals when taken as daily supplements. Click here to read information about Nutrivene Longvida Curcumin.